Stephanie Champion, MD
Obstetrics & Gynecology · Houston, TXNPI 1518130459
Payments from drug & device makers
Across 147 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$486
- Avion Pharmaceuticals$236
- Exeltis, USA Inc.$189
- Mayne Pharma Commercial LLC$173
- Astellas Pharma US Inc$138
- Biogen$135
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,49299%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $486 |
| Avion Pharmaceuticals | 16 | $236 |
| Exeltis, USA Inc. | 10 | $189 |
| Mayne Pharma Commercial LLC | 13 | $173 |
| Astellas Pharma US Inc | 6 | $138 |
| Biogen | 6 | $135 |
| Pfizer | 5 | $117 |
| Merck | 7 | $113 |
| Organon | 10 | $103 |
| Sumitomo Pharma America, Inc. | 4 | $102 |
| Lupin Inc. | 5 | $79 |
| Millicent US Inc | 4 | $68 |
| Aspira Women's Health Inc | 1 | $66 |
| Bayer | 3 | $51 |
| Agile Therapeutics, Inc. | 3 | $47 |
| Therapeuticsmd, Inc. | 2 | $41 |
| Evofem Biosciences, Inc. | 2 | $36 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Mylan Pharmaceuticals Inc. | 2 | $34 |
| AMAG Pharmaceuticals, Inc. | 2 | $30 |
| Coopersurgical, Inc. | 2 | $29 |
| Boston Scientific | 1 | $24 |
| Acessa Health Inc. | 1 | $24 |
| Optumhealth Care Solutions, LLC | 1 | $23 |
| Duchesnay USA Incorporated | 1 | $22 |
| Intuitive Surgical | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Biom'up France SAS | 1 | $20 |
| Smith+Nephew | 1 | $17 |
| Kesin Pharma Corporation | 1 | $16 |
| Scynexis, Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $11 |
How this compares
$2,522 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 14 | $701 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Houston
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Mark JacobsHouston$2.8M
- Sandra HurtadoHouston$1.7M
- Dawn BlackHouston$1.2M
- George KuhnHouston$244K
- Luis Sandoval-MartinezHouston$234K
- Daisy AyimHouston$188K
- Asha BhalwalHouston$151K
- Monica LopezFort Worth$8.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.